APA

Corazzelli G., Frigeri F., Arcamone M., Lucania A., Rosariavilla M., Morelli E., Amore A., Capobianco G., Caronna A., Becchimanzi C., Volzone F., Marcacci G., Russo F., De Filippi R., Mastrullo L. & Pinto A. (20111027). Biweekly rituximab, cyclophosphamide, vincristine, non-pegylated liposome-encapsulated doxorubicin and prednisone (R-COMP-14) in elderly patients with poor-risk diffuse large B-cell lymphoma and moderate to high 'life threat' impact cardiopathy. : British journal of haematology.

Chicago

Corazzelli Gaetano, Frigeri Ferdinando, Arcamone Manuela, Lucania Anna, Rosariavilla Maria, Morelli Emanuela, Amore Alfonso, Capobianco Gaetana, Caronna Antonietta, Becchimanzi Cristina, Volzone Francesco, Marcacci Gianpaolo, Russo Filippo, De Filippi Rosaria, Mastrullo Lucia and Pinto Antonio. 20111027. Biweekly rituximab, cyclophosphamide, vincristine, non-pegylated liposome-encapsulated doxorubicin and prednisone (R-COMP-14) in elderly patients with poor-risk diffuse large B-cell lymphoma and moderate to high 'life threat' impact cardiopathy. : British journal of haematology.

Harvard

Corazzelli G., Frigeri F., Arcamone M., Lucania A., Rosariavilla M., Morelli E., Amore A., Capobianco G., Caronna A., Becchimanzi C., Volzone F., Marcacci G., Russo F., De Filippi R., Mastrullo L. and Pinto A. (20111027). Biweekly rituximab, cyclophosphamide, vincristine, non-pegylated liposome-encapsulated doxorubicin and prednisone (R-COMP-14) in elderly patients with poor-risk diffuse large B-cell lymphoma and moderate to high 'life threat' impact cardiopathy. : British journal of haematology.

MLA

Corazzelli Gaetano, Frigeri Ferdinando, Arcamone Manuela, Lucania Anna, Rosariavilla Maria, Morelli Emanuela, Amore Alfonso, Capobianco Gaetana, Caronna Antonietta, Becchimanzi Cristina, Volzone Francesco, Marcacci Gianpaolo, Russo Filippo, De Filippi Rosaria, Mastrullo Lucia and Pinto Antonio. Biweekly rituximab, cyclophosphamide, vincristine, non-pegylated liposome-encapsulated doxorubicin and prednisone (R-COMP-14) in elderly patients with poor-risk diffuse large B-cell lymphoma and moderate to high 'life threat' impact cardiopathy. : British journal of haematology. 20111027.